The potential for prevention of dementia across two decades: The prospective, population-based Rotterdam Study

BMC Medicine

Volumn 13, Issue 1, 2015, Pages

  de Bruijn, Renée F A G ^a   Bos, Michiel J ^a   Portegies, Marileen L P ^a   Hofman, Albert ^a   Franco, Oscar H ^a   Koudstaal, Peter J ^a   Ikram, M Arfan ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Dementia; Epidemiology; Population attributable risk; Risk factors

Indexed keywords

CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL;

AGED; ARTICLE; ATRIAL FIBRILLATION; ATTRIBUTABLE RISK; CEREBROVASCULAR ACCIDENT; CHOLESTEROL BLOOD LEVEL; DEMENTIA; DIABETES MELLITUS; EDUCATIONAL STATUS; FEMALE; HEART FAILURE; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; OBESITY; POPULATION RESEARCH; PROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SMOKING; VERY ELDERLY; CARDIOVASCULAR DISEASES; HEALTH EDUCATION; HYPERCHOLESTEROLEMIA; LONGITUDINAL STUDY; MIDDLE AGED; NETHERLANDS; ORGANIZATION AND MANAGEMENT; OVERWEIGHT; PREVENTIVE MEDICINE; PROCEDURES; RISK REDUCTION;

AGED; CARDIOVASCULAR DISEASES; CAUSALITY; DEMENTIA; DIABETES MELLITUS; EFFECT MODIFIER, EPIDEMIOLOGIC; FEMALE; HEALTH EDUCATION; HUMANS; HYPERCHOLESTEROLEMIA; HYPERTENSION; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; NETHERLANDS; OVERWEIGHT; PREVENTIVE MEDICINE; PROSPECTIVE STUDIES; RISK FACTORS; RISK REDUCTION BEHAVIOR; SMOKING;

EID: 84937239533     PISSN: None     EISSN: 17417015     Source Type: Journal    
DOI: 10.1186/s12916-015-0377-5     Document Type: Article

References (35)

1. Qiu C, Xu W, Fratiglioni L. Vascular and psychosocial factors in Alzheimer's disease: epidemiological evidence toward intervention. J Alzheimers Dis. 2010;20:689-97.
2. Middleton LE, Yaffe K. Targets for the prevention of dementia. J Alzheimers Dis. 2010;20:915-24.
3. Alzheimer's Disease International. World Alzheimer Report 2014. Dementia and Risk Reduction: an analysis of protective and modifiable factors. http://www.alz.co.uk/research/world-report-2014 .
4. Rothman K, Greenland S. Modern epidemiology. 2nd ed. Philadelphia: Lippincott Williams & Wilkins; 1998.
5. Lipnicki DM, Sachdev PS, Crawford J, Reppermund S, Kochan NA, Trollor JN, et al. Risk factors for late-life cognitive decline and variation with age and sex in the Sydney Memory and Ageing Study. PLoS One. 2013;8, e65841.
6. Barnes DE, Yaffe K. The projected effect of risk factor reduction on Alzheimer's disease prevalence. Lancet Neurol. 2011;10:819-28.
7. Dodge HH, Chang CC, Kamboh IM, Ganguli M. Risk of Alzheimer's disease incidence attributable to vascular disease in the population. Alzheimers Dement. 2011;7:356-60.
8. Norton S, Matthews FE, Barnes DE, Yaffe K, Brayne C. Potential for primary prevention of Alzheimer's disease: an analysis of population-based data. Lancet Neurol. 2014;13:788-94.
9. Ritchie K, Carriere I, Ritchie CW, Berr C, Artero S, Ancelin ML. Designing prevention programmes to reduce incidence of dementia: prospective cohort study of modifiable risk factors. BMJ. 2010;341:c3885.
10. Kloppenborg RP, van den Berg E, Kappelle LJ, Biessels GJ. Diabetes and other vascular risk factors for dementia: which factor matters most? A systematic review. Eur J Pharmacol. 2008;585:97-108.
11. Schrijvers EM, Verhaaren BF, Koudstaal PJ, Hofman A, Ikram MA, Breteler MM. Is dementia incidence declining? Trends in dementia incidence since 1990 in the Rotterdam Study. Neurology. 2012;78:1456-63.
12. Qiu C, von Strauss E, Backman L, Winblad B, Fratiglioni L. Twenty-year changes in dementia occurrence suggest decreasing incidence in central Stockholm, Sweden. Neurology. 2013;80:1888-94.
13. Matthews FE, Arthur A, Barnes LE, Bond J, Jagger C, Robinson L, et al. A two-decade comparison of prevalence of dementia in individuals aged 65 years and older from three geographical areas of England: results of the Cognitive Function and Ageing Study I and II. Lancet. 2013;382:1405-12.
14. Lobo A, Saz P, Marcos G, Dia JL, De-la-Camara C, Ventura T, et al. Prevalence of dementia in a southern European population in two different time periods: the ZARADEMP Project. Acta Psychiatr Scand. 2007;116:299-307.
15. Langa KM, Larson EB, Karlawish JH, Cutler DM, Kabeto MU, Kim SY, et al. Trends in the prevalence and mortality of cognitive impairment in the United States: is there evidence of a compression of cognitive morbidity? Alzheimers Dement. 2008;4:134-44.
16. Hofman A, Darwish Murad S, van Duijn CM, Franco OH, Goedegebure A, Ikram MA, et al. The Rotterdam Study: 2014 objectives and design update. Eur J Epidemiol. 2013;28:889-926.
17. Savva GM, Stephan BC, Alzheimer's Society Vascular Dementia Systematic Review Group. Epidemiological studies of the effect of stroke on incident dementia: a systematic review. Stroke. 2010;41:e41-6.
18. Roberts RO, Knopman DS, Geda YE, Cha RH, Roger VL, Petersen RC. Coronary heart disease is associated with non-amnestic mild cognitive impairment. Neurobiol Aging. 2010;31:1894-902.
19. Qiu C, Winblad B, Marengoni A, Klarin I, Fastbom J, Fratiglioni L. Heart failure and risk of dementia and Alzheimer disease: a population-based cohort study. Arch Intern Med. 2006;166:1003-8.
20. Dublin S, Anderson ML, Haneuse SJ, Heckbert SR, Crane PK, Breitner JC, et al. Atrial fibrillation and risk of dementia: a prospective cohort study. J Am Geriatr Soc. 2011;59:1369-75.
21. Wieberdink RG, Ikram MA, Hofman A, Koudstaal PJ, Breteler MM. Trends in stroke incidence rates and stroke risk factors in Rotterdam, the Netherlands from 1990 to 2008. Eur J Epidemiol. 2012;27:287-95.
22. Leening MJ, Kavousi M, Heeringa J, van Rooij FJ, Verkroost-van Heemst J, Deckers JW, et al. Methods of data collection and definitions of cardiac outcomes in the Rotterdam Study. Eur J Epidemiol. 2012;27:173-85.
23. Interactive Risk Attributable Program, version 2.2. http://dceg.cancer.gov/tools/risk-assessment/irap . Date last accessed: May 28, 2014.
24. Leung HM, Kupper LL. Comparisons of confidence intervals for attributable risk. Biometrics. 1981;37:293-302.
25. Benichou J. Biostatistics and epidemiology: measuring the risk attributable to an environmental or genetic factor. C R Biol. 2007;330:281-98.
26. Dehghan A, van Hoek M, Sijbrands EJ, Stijnen T, Hofman A, Witteman JC. Risk of type 2 diabetes attributable to C-reactive protein and other risk factors. Diabetes Care. 2007;30:2695-9.
27. Bos MJ, Koudstaal PJ, Hofman A, Ikram MA. Modifiable etiological factors and the burden of stroke from the Rotterdam study: a population-based cohort study. PLoS Med. 2014;11, e1001634.
28. Tolppanen AM, Ngandu T, Kareholt I, Laatikainen T, Rusanen M, Soininen H, et al. Midlife and late-life body mass index and late-life dementia: results from a prospective population-based cohort. J Alzheimers Dis. 2014;38:201-9.
29. Qiu C, Winblad B, Fratiglioni L. The age-dependent relation of blood pressure to cognitive function and dementia. Lancet Neurol. 2005;4:487-99.
30. Anstey KJ, Lipnicki DM, Low LF. Cholesterol as a risk factor for dementia and cognitive decline: a systematic review of prospective studies with meta-analysis. Am J Geriatr Psychiatry. 2008;16:343-54.
31. Egan BM, Zhao Y, Axon RN. US trends in prevalence, awareness, treatment, and control of hypertension, 1988-2008. JAMA. 2010;303:2043-50.
32. Gregg EW, Li Y, Wang J, Burrows NR, Ali MK, Rolka D, et al. Changes in diabetes-related complications in the United States, 1990-2010. N Engl J Med. 2014;370:1514-23.
33. Ng M, Fleming T, Robinson M, Thomson B, Graetz N, Margono C, et al. Global, regional, and national prevalence of overweight and obesity in children and adults during 1980-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2014;384:766-81.
34. Lakshminarayan K, Solid CA, Collins AJ, Anderson DC, Herzog CA. Atrial fibrillation and stroke in the general medicare population: a 10-year perspective (1992 to 2002). Stroke. 2006;37:1969-74.
35. Schmidt M, Jacobsen JB, Johnsen SP, Botker HE, Sorensen HT. Eighteen-year trends in stroke mortality and the prognostic influence of comorbidity. Neurology. 2014;82:340-50.